Low concentrations of adropin are associated with endothelial dysfunction as assessed by flow-mediated dilatation in patients with metabolic syndrome

In individuals with atherosclerotic risk factors, endothelial dysfunction (ED) appears as an early phase in the development of clinical symptoms. Recent studies indicate that adropin, a newly identified peptide, participates in cardiovascular health through the regulation of several metabolic events...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical chemistry and laboratory medicine 2017-01, Vol.55 (1), p.139-144
Hauptverfasser:	Oruc, Coskun U., Akpinar, Yunus E., Dervisoglu, Elmire, Amikishiyev, Shirkhan, Salmaslıoglu, Artur, Gurdol, Figen, Omer, Beyhan
Format:	Artikel
Sprache:	eng
Schlagworte:	adropin Angiogenesis Arteriosclerosis Atherosclerosis Biochemistry Blood flow Blood Proteins - metabolism Circulation Dilatation endothelial dysfunction endothelial nitric oxide synthase Endothelin 1 Endothelium, Vascular - metabolism Endothelium, Vascular - pathology Fasting flow-mediated dilatation Glucose Humans Insulin Low concentrations Metabolic syndrome Metabolic Syndrome - diagnosis Metabolic Syndrome - metabolism Nitric oxide Nitric-oxide synthase Nitrogen oxides Patients Peptides - blood Peptides - metabolism Regression analysis Risk analysis Risk factors Stretching Subgroups Ultrasound
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!